Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer’s disease

Elena Galea, Laura D. Weinstock, Raquel Larramona-Arcas, Alyssa F. Pybus, Lydia Giménez-Llort, Carole Escartin, Levi B. Wood
doi: https://doi.org/10.1101/2021.02.25.21252422
Elena Galea
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
2Departament de Bioquímica, Unitat de Bioquímica, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
3ICREA, 08010 Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: levi.wood{at}me.gatech.edu Elena.Galea{at}uab.es
Laura D. Weinstock
4Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 30332 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Larramona-Arcas
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
2Departament de Bioquímica, Unitat de Bioquímica, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyssa F. Pybus
4Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 30332 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydia Giménez-Llort
1Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
5Departament de Psiquiatria i Medicina Forense, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carole Escartin
6Université Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, 92265, Fontenay-aux-Roses, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levi B. Wood
4Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 30332 USA
7George W. Woodruff School of Mechanical Engineering and Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, 30332 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: levi.wood{at}me.gatech.edu Elena.Galea{at}uab.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Recent single-nucleus RNA sequencing of astrocytes in postmortem Alzheimer’s disease (AD) samples is limited by the low number of sequenced astrocytes and small cohort sizes. We developed a systems biology approach to identify astrocytic genes in public large bulk AD transcriptomes. Brain cell specific gene clusters were generated from RNA sequencing data from isolated healthy human brain cells using cell-type enrichment scoring and clustering. Cell-specific gene clusters were localized in whole-brain transcriptomes from 766 subjects diagnosed with AD or mild cognitive impairment (MCI) from the Mount Sinai Hospital, the Mayo Clinic, and the Religious Order Study/Memory and Aging Project (ROSMAP). Gene clusters were organized into manually curated functional categories including astrocytic categories absent from existing platforms, such as perisynaptic astrocytic processes (PAP). Changes among subjects were determined by gene set variation analysis (GSVA) and principal component analysis (PCA). Hierarchical clustering revealed molecular heterogeneity in individuals with the same clinical diagnosis. Particularly in the Mayo Clinic and ROSMAP cohorts, over 50% of Controls presented the massive down-regulation of genes encoding synaptic proteins typical of AD, whereas 30% of AD patients presented Control-like transcriptomic profiles. According to GSVA and PCA, down-regulation of neuronal genes related to synaptic proteins correlated with down-regulation of astrocytic genes encoding mitochondrial and endolysosomal proteins, and up-regulation of genes related to PAP. Transcriptomic data thus unravel a deep phenotypic transformation of human astrocytes in AD, affecting organelles and astrocyte-neuron interactions. We posit that therapies preventing organelle dysfunction in astrocytes may protect neural circuits in preclinical and clinical AD.

Main points

  1. Transcriptomes of control subjects and AD patients segregate in two main molecular profiles regardless of clinical diagnosis.

  2. Dysregulation of the endolysosomal/mitochondrial axis in astrocytes correlates with impaired synaptic plasticity in neurons.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This study analyzed publicly available data and was not a clinical trial.

Funding Statement

This work was supported by Fundacio Marato-TV3 (grant number 201414-30), and Grup de Recerca en demencias: Sant Pau SGR2017547, Generalitat de Catalunya (E.G.), by funds from the Coins for Alzheimer's Research Trust (L.B.W.) and startup funds from the Woodruff School of Mechanical Engineering at Georgia Tech (L.B.W.). L.D.W. and A.F.P were supported in part by the National Institutes of Health Cell and Tissue Engineering Biotechnology Training Grant (T32-GM008433). CNRS, CEA and France Alzheimer (C.E.). The results published here are in whole or in part based on data obtained from the AD Knowledge Portal ( https://adknowledgeportal.synapse.org ). Study data were provided by the following sources: The Mayo Clinic Alzheimers Disease Genetic Studies, led by Dr. Nilufer Ertekin-Taner and Dr. Steven G. Younkin, Mayo Clinic, Jacksonville, FL using samples from the Mayo Clinic Study of Aging, the Mayo Clinic Alzheimers Disease Research Center, and the Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, NINDS grant R01 NS080820, CurePSP Foundation, and support from Mayo Founda-tion. Study data includes samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Ser-vices (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Study data were also provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161 (ROS), R01AG15819 (ROSMAP; genomics and RNAseq), R01AG17917 (MAP), R01AG30146, R01AG36042 (5hC methylation, ATACseq), RC2AG036547 (H3K9Ac), R01AG36836 (RNAseq), R01AG48015 (monocyte RNAseq) RF1AG57473 (single nucleus RNAseq), U01AG32984 (genomic and whole exome sequencing), U01AG46152 (ROSMAP AMP-AD, targeted proteomics), U01AG46161(TMT proteomics), U01AG61356 (whole genome sequencing, targeted proteomics, ROSMAP AMP-AD), the Illinois Department of Public Health (ROSMAP), and the Translational Genomics Research Institute (genomic). ROSMAP data can be requested at www.radc.rush.edu.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work used publicly available de-identified transcriptomic data and thus did not require IRB approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Authors state no conflict of interest

  • Added discussion to further compare our findings against other published reports.

Data Availability

All datasets are public and identifiers are noted for each dataset used.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 30, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer’s disease
Elena Galea, Laura D. Weinstock, Raquel Larramona-Arcas, Alyssa F. Pybus, Lydia Giménez-Llort, Carole Escartin, Levi B. Wood
medRxiv 2021.02.25.21252422; doi: https://doi.org/10.1101/2021.02.25.21252422
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer’s disease
Elena Galea, Laura D. Weinstock, Raquel Larramona-Arcas, Alyssa F. Pybus, Lydia Giménez-Llort, Carole Escartin, Levi B. Wood
medRxiv 2021.02.25.21252422; doi: https://doi.org/10.1101/2021.02.25.21252422

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)